Blinatumomab Consolidation in Real World

Official record

Identifier

NCT07117136

Recruiting locations

country

United States

Interventions studied

Not provided in the official record

Lead sponsor

Medical College of Wisconsin

Target enrolment

200 participants

Study type

OBSERVATIONAL

Phase

Not provided in the official record

Status

Recruiting

First posted

Aug 12, 2025

Last updated on the registry

Oct 1, 2026

Age

18 Years

Sex

ALL

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* 1\) aged 18 years or older 2) diagnosed with B-ALL on or after December 1st 2022 3) Not received blinatumomab in an interventional clinical trial setting 4) Willing and able to give informed consent (or retrospective data for deceased patients

Exclusion Criteria:

* N/A

Indexed under

Leukemia